These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 38044089)
1. Innovative System for Delivering Nucleic Acids/Genes Based on Controlled Intracellular Trafficking as Well as Controlled Biodistribution for Nanomedicines. Harashima H Biol Pharm Bull; 2023; 46(12):1648-1660. PubMed ID: 38044089 [TBL] [Abstract][Full Text] [Related]
2. Evolution of drug delivery system from viewpoint of controlled intracellular trafficking and selective tissue targeting toward future nanomedicine. Yamada Y; Sato Y; Nakamura T; Harashima H J Control Release; 2020 Nov; 327():533-545. PubMed ID: 32916227 [TBL] [Abstract][Full Text] [Related]
12. Development of a multifunctional envelope-type nano device and its application to nanomedicine. Sato Y; Nakamura T; Yamada Y; Harashima H J Control Release; 2016 Dec; 244(Pt B):194-204. PubMed ID: 27374187 [TBL] [Abstract][Full Text] [Related]
13. Extrahepatic targeting of lipid nanoparticles in vivo with intracellular targeting for future nanomedicines. Nakamura T; Sato Y; Yamada Y; Abd Elwakil MM; Kimura S; Younis MA; Harashima H Adv Drug Deliv Rev; 2022 Sep; 188():114417. PubMed ID: 35787389 [TBL] [Abstract][Full Text] [Related]
14. On the mechanism of tissue-selective gene delivery by lipid nanoparticles. Kimura S; Harashima H J Control Release; 2023 Oct; 362():797-811. PubMed ID: 37004796 [TBL] [Abstract][Full Text] [Related]
15. Effect of cationic carriers on the pharmacokinetics and tumor localization of nucleic acids after intravenous administration. de Wolf HK; Snel CJ; Verbaan FJ; Schiffelers RM; Hennink WE; Storm G Int J Pharm; 2007 Mar; 331(2):167-75. PubMed ID: 17134859 [TBL] [Abstract][Full Text] [Related]
16. Design of Ionizable Lipids To Overcome the Limiting Step of Endosomal Escape: Application in the Intracellular Delivery of mRNA, DNA, and siRNA. Habrant D; Peuziat P; Colombani T; Dallet L; Gehin J; Goudeau E; Evrard B; Lambert O; Haudebourg T; Pitard B J Med Chem; 2016 Apr; 59(7):3046-62. PubMed ID: 26943260 [TBL] [Abstract][Full Text] [Related]
17. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA. Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441 [TBL] [Abstract][Full Text] [Related]
18. Nucleic Acid Delivery by Solid Lipid Nanoparticles Containing Switchable Lipids: Plasmid DNA vs. Messenger RNA. Gómez-Aguado I; Rodríguez-Castejón J; Vicente-Pascual M; Rodríguez-Gascón A; Pozo-Rodríguez AD; Solinís Aspiazu MÁ Molecules; 2020 Dec; 25(24):. PubMed ID: 33352904 [TBL] [Abstract][Full Text] [Related]
19. Multifunctional Envelope-Type Nano Device: Evolution from Nonselective to Active Targeting System. Hayashi Y; Hatakeyama H; Kajimoto K; Hyodo M; Akita H; Harashima H Bioconjug Chem; 2015 Jul; 26(7):1266-76. PubMed ID: 25938819 [TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and biodistribution of recently-developed siRNA nanomedicines. Park J; Park J; Pei Y; Xu J; Yeo Y Adv Drug Deliv Rev; 2016 Sep; 104():93-109. PubMed ID: 26686832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]